{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:01:06Z","timestamp":1760576466847,"version":"build-2065373602"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068614-14","UM1 AI068635","3UM1AI068618-15S1","T32AI007044-45"],"award-info":[{"award-number":["UM1 AI068614-14","UM1 AI068635","3UM1AI068618-15S1","T32AI007044-45"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021281","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV007217"],"award-info":[{"award-number":["INV007217"]}],"id":[{"id":"10.13039\/100021281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>mRNA vaccines have emerged as powerful tools for the prevention of infectious diseases, but subclinical malaria may reduce vaccine immunogenicity. We evaluated neutralizing antibody responses in asymptomatic HIV-infected adults with and without polymerase chain reaction-confirmed Plasmodium falciparum who received either monovalent mRNA-1273 or bivalent mRNA-1273.222 (WA-1 and BA.4\/5) booster vaccines. In previous studies, a 50% pseudovirus inhibitory dose neutralizing antibody (ID50) titer of 1000 correlated with 96% efficacy in preventing COVID-19. We observed ID50 geometric mean titers &amp;gt;22 000 in both parasitemic and nonparasitemic participants 1 month after boosting. We conclude that COVID-19 mRNA vaccine antibody responses are unimpaired by concurrent asymptomatic parasitemia.<\/jats:p>","DOI":"10.1093\/infdis\/jiaf398","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T08:17:27Z","timestamp":1754122647000},"page":"e565-e570","source":"Crossref","is-referenced-by-count":0,"title":["<i>Plasmodium falciparum<\/i> Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-6108","authenticated-orcid":false,"given":"Taraz","family":"Samandari","sequence":"first","affiliation":[{"name":"COVID-19 Prevention Network , Seattle, Washington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Millicent","family":"Achola","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Directorate-Africa , Kisumu ,","place":["Kenya"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack N","family":"Hutter","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Directorate-Africa , Kisumu ,","place":["Kenya"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Mboya","sequence":"additional","affiliation":[{"name":"Kenya Medical Research Institute, Centre for Global Health Research , Kisumu ,","place":["Kenya"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Otieno","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Directorate-Africa , Kisumu ,","place":["Kenya"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Jin","family":"Kee","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunda","family":"Huang","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","place":["USA"]},{"name":"Department of Global Health, University of Washington , Seattle, Washtington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3014-3673","authenticated-orcid":false,"given":"John J","family":"Aponte","sequence":"additional","affiliation":[{"name":"PATH Center for Vaccine Innovation and Access , Geneva ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9715-7064","authenticated-orcid":false,"given":"Christian F","family":"Ockenhouse","sequence":"additional","affiliation":[{"name":"PATH Center for Vaccine Innovation and Access , Washington, District of Columbia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia K","family":"Lee","sequence":"additional","affiliation":[{"name":"PATH Center for Vaccine Innovation and Access , Washington, District of Columbia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-7632","authenticated-orcid":false,"given":"Laura","family":"Polakowski","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-8560","authenticated-orcid":false,"given":"Margaret","family":"Yacovone","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3206-1708","authenticated-orcid":false,"given":"Asa","family":"Tapley","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","place":["USA"]},{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington , Seattle, Washington ,","place":["USA"]},{"name":"Department of Medicine, University of Cape Town , Cape Town ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sufia","family":"Dadabhai","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health , Blantyre ,","place":["Malawi"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla N","family":"Mkhize","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases of the National Health Laboratory Services , Johannesburg ,","place":["South Africa"]},{"name":"SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haajira","family":"Kaldine","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases of the National Health Laboratory Services , Johannesburg ,","place":["South Africa"]},{"name":"SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinethemba","family":"Bhebhe","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases of the National Health Laboratory Services , Johannesburg ,","place":["South Africa"]},{"name":"SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny L","family":"Moore","sequence":"additional","affiliation":[{"name":"National Institute for Communicable Diseases of the National Health Laboratory Services , Johannesburg ,","place":["South Africa"]},{"name":"SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Hural","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4530-234X","authenticated-orcid":false,"given":"Nigel","family":"Garrett","sequence":"additional","affiliation":[{"name":"Desmond Tutu HIV Centre, University of Cape Town , Cape Town ,","place":["South Africa"]},{"name":"Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal , Durban ,","place":["South Africa"]},{"name":"Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal , Durban ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G","family":"Kublin","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center , Seattle, Washington ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"2025101515145053000_jiaf398-B1","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S2666-5247(21)00240-8","article-title":"Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda","volume":"3","author":"Achan","year":"2022","journal-title":"Lancet Microb"},{"key":"2025101515145053000_jiaf398-B2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12879-022-07064-4","article-title":"Low incidence of COVID-19 case severity and mortality in Africa; could malaria co-infection provide the missing link?","volume":"22","author":"Osei","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025101515145053000_jiaf398-B3","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/pim.13067","article-title":"The effect of malaria on responses to unrelated vaccines in animals and humans: a systematic review and meta-analysis","volume":"46","author":"Zirmenya","year":"2024","journal-title":"Parasite Immunol"},{"key":"2025101515145053000_jiaf398-B4","doi-asserted-by":"crossref","first-page":"e6465","DOI":"10.1371\/journal.pone.0006465","article-title":"Evaluation of RTS,S\/AS02A and RTS,S\/AS01B in adults in a high malaria transmission area","volume":"4","author":"Polhemus","year":"2009","journal-title":"PLoS One"},{"key":"2025101515145053000_jiaf398-B5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4049\/jimmunol.1202438","article-title":"Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion","volume":"190","author":"Illingworth","year":"2013","journal-title":"J Immunol"},{"key":"2025101515145053000_jiaf398-B6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"2025101515145053000_jiaf398-B7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1086\/429298","article-title":"Compromised B cell responses to influenza vaccination in HIV-infected individuals","volume":"191","author":"Malaspina","year":"2005","journal-title":"J Infect Dis"},{"key":"2025101515145053000_jiaf398-B8","first-page":"103054","article-title":"Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 study","volume":"80","author":"Garrett","year":"2025","journal-title":"eClin Med"},{"key":"2025101515145053000_jiaf398-B9","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/JCM.00276-11","article-title":"Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of plasmodium by amplifying RNA and DNA of the 18S rRNA genes","volume":"49","author":"Kamau","year":"2011","journal-title":"J Clin Micro"},{"key":"2025101515145053000_jiaf398-B10","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41596-021-00536-y","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays","volume":"16","author":"Bewley","year":"2021","journal-title":"Nat Protoc"},{"key":"2025101515145053000_jiaf398-B11","doi-asserted-by":"crossref","first-page":"23921","DOI":"10.1038\/s41598-021-03154-6","article-title":"Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"key":"2025101515145053000_jiaf398-B12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"author":"Elyanu","key":"2025101515145053000_jiaf398-B13"},{"key":"2025101515145053000_jiaf398-B14","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiab243","article-title":"Baseline asymptomatic malaria infection and immunogenicity of recombinant vesicular stomatitis virus-Zaire ebola virus envelope glycoprotein","volume":"224","author":"Mahon","year":"2021","journal-title":"J Infect Dis"},{"key":"2025101515145053000_jiaf398-B15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12879-023-08699-7","article-title":"Background malaria incidence and parasitemia during the three-dose RTS,S\/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria","volume":"23","author":"Bell","year":"2023","journal-title":"BMC Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf398\/63923646\/jiaf398.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/4\/e565\/63923646\/jiaf398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/4\/e565\/63923646\/jiaf398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:17:12Z","timestamp":1760555832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/4\/e565\/8221348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,2]]},"published-print":{"date-parts":[[2025,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf398","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2025,10,15]]},"published":{"date-parts":[[2025,8,2]]}}}